

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 6.56270583 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 6.27494348 |
| 3 | fat-soluble vitamin catabolic process (GO:0042363) | 5.62942331 |
| 4 | vitamin catabolic process (GO:0009111) | 5.62942331 |
| 5 | desmosome organization (GO:0002934) | 5.59078319 |
| 6 | endocardial cushion morphogenesis (GO:0003203) | 4.89791499 |
| 7 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.76228544 |
| 8 | pattern specification involved in kidney development (GO:0061004) | 4.74365671 |
| 9 | regulation of male gonad development (GO:2000018) | 4.51381501 |
| 10 | mesenchyme morphogenesis (GO:0072132) | 4.35393445 |
| 11 | photoreceptor cell differentiation (GO:0046530) | 4.33750217 |
| 12 | eye photoreceptor cell differentiation (GO:0001754) | 4.33750217 |
| 13 | behavioral response to ethanol (GO:0048149) | 4.32388336 |
| 14 | limb bud formation (GO:0060174) | 4.26368420 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.24455778 |
| 16 | nephron tubule formation (GO:0072079) | 4.16650202 |
| 17 | protein localization to synapse (GO:0035418) | 4.13434777 |
| 18 | tachykinin receptor signaling pathway (GO:0007217) | 4.08731165 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.08501752 |
| 20 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.04875097 |
| 21 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.02134943 |
| 22 | vocalization behavior (GO:0071625) | 4.00070823 |
| 23 | nucleobase catabolic process (GO:0046113) | 3.96427545 |
| 24 | positive regulation of action potential (GO:0045760) | 3.93754715 |
| 25 | diterpenoid biosynthetic process (GO:0016102) | 3.92626264 |
| 26 | gamma-aminobutyric acid transport (GO:0015812) | 3.92429826 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 3.83337759 |
| 28 | synaptic vesicle maturation (GO:0016188) | 3.80906507 |
| 29 | Sertoli cell development (GO:0060009) | 3.79653623 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 3.77725027 |
| 31 | otic vesicle formation (GO:0030916) | 3.75300532 |
| 32 | positive regulation of male gonad development (GO:2000020) | 3.71100793 |
| 33 | synaptic transmission, glutamatergic (GO:0035249) | 3.67839468 |
| 34 | regulation of gene silencing by RNA (GO:0060966) | 3.63205111 |
| 35 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.63205111 |
| 36 | regulation of gene silencing by miRNA (GO:0060964) | 3.63205111 |
| 37 | lymph vessel development (GO:0001945) | 3.62696719 |
| 38 | short-term memory (GO:0007614) | 3.62415481 |
| 39 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.57155959 |
| 40 | regulation of timing of cell differentiation (GO:0048505) | 3.54467138 |
| 41 | neurofilament cytoskeleton organization (GO:0060052) | 3.47088804 |
| 42 | endothelium development (GO:0003158) | 3.41259736 |
| 43 | atrioventricular valve morphogenesis (GO:0003181) | 3.39350259 |
| 44 | signal complex assembly (GO:0007172) | 3.36222930 |
| 45 | heart valve formation (GO:0003188) | 3.36125391 |
| 46 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.35350825 |
| 47 | gland morphogenesis (GO:0022612) | 3.35003396 |
| 48 | C4-dicarboxylate transport (GO:0015740) | 3.32951000 |
| 49 | mesonephros development (GO:0001823) | 3.32390822 |
| 50 | negative chemotaxis (GO:0050919) | 3.26265209 |
| 51 | neuronal action potential (GO:0019228) | 3.25803786 |
| 52 | negative regulation of myoblast differentiation (GO:0045662) | 3.24880683 |
| 53 | positive regulation of protein kinase C signaling (GO:0090037) | 3.24281734 |
| 54 | postsynaptic membrane organization (GO:0001941) | 3.23752105 |
| 55 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.23017463 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 3.22807790 |
| 57 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.20507740 |
| 58 | urinary tract smooth muscle contraction (GO:0014848) | 3.20456036 |
| 59 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.18768013 |
| 60 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.17622590 |
| 61 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.15962941 |
| 62 | membrane depolarization during action potential (GO:0086010) | 3.13889368 |
| 63 | regulation of development, heterochronic (GO:0040034) | 3.13110703 |
| 64 | heart valve morphogenesis (GO:0003179) | 3.12995854 |
| 65 | negative regulation of cell fate specification (GO:0009996) | 3.11431782 |
| 66 | neuron recognition (GO:0008038) | 3.10684096 |
| 67 | neural crest cell development (GO:0014032) | 3.09834814 |
| 68 | positive regulation of extracellular matrix organization (GO:1903055) | 3.07717432 |
| 69 | negative regulation of hormone metabolic process (GO:0032351) | 3.06694237 |
| 70 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.06694237 |
| 71 | mesenchymal to epithelial transition (GO:0060231) | 3.05367285 |
| 72 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.05151153 |
| 73 | response to auditory stimulus (GO:0010996) | 3.04580847 |
| 74 | developmental pigmentation (GO:0048066) | 3.04011876 |
| 75 | regulation of action potential (GO:0098900) | 3.03643531 |
| 76 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.02181695 |
| 77 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.02181695 |
| 78 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.00434490 |
| 79 | proximal/distal pattern formation (GO:0009954) | 2.99432710 |
| 80 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.98340563 |
| 81 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.98340563 |
| 82 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.98340563 |
| 83 | transmission of nerve impulse (GO:0019226) | 2.96586376 |
| 84 | righting reflex (GO:0060013) | 2.96585005 |
| 85 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.96080732 |
| 86 | presynaptic membrane assembly (GO:0097105) | 2.96014796 |
| 87 | negative regulation of catenin import into nucleus (GO:0035414) | 2.95525738 |
| 88 | positive regulation of cartilage development (GO:0061036) | 2.94985491 |
| 89 | glucosamine-containing compound catabolic process (GO:1901072) | 2.93759225 |
| 90 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.91618010 |
| 91 | establishment of planar polarity (GO:0001736) | 2.90457934 |
| 92 | establishment of tissue polarity (GO:0007164) | 2.90457934 |
| 93 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.90129582 |
| 94 | cell migration in hindbrain (GO:0021535) | 2.88920539 |
| 95 | regulation of collateral sprouting (GO:0048670) | 2.87475271 |
| 96 | establishment of mitochondrion localization (GO:0051654) | 2.83650271 |
| 97 | chondrocyte development (GO:0002063) | 2.83265414 |
| 98 | axonal fasciculation (GO:0007413) | 2.83245549 |
| 99 | histone H3-K4 trimethylation (GO:0080182) | 2.82319826 |
| 100 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.82194703 |
| 101 | epoxygenase P450 pathway (GO:0019373) | 2.81988912 |
| 102 | retinal cone cell development (GO:0046549) | 2.81695144 |
| 103 | establishment of skin barrier (GO:0061436) | 2.80832785 |
| 104 | terpenoid biosynthetic process (GO:0016114) | 2.80753215 |
| 105 | male sex determination (GO:0030238) | 2.80386921 |
| 106 | negative regulation of cell fate commitment (GO:0010454) | 2.79769740 |
| 107 | facial nerve structural organization (GO:0021612) | 2.78590190 |
| 108 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.78568297 |
| 109 | skin morphogenesis (GO:0043589) | 2.78535299 |
| 110 | regulation of glomerulus development (GO:0090192) | 2.76588882 |
| 111 | positive regulation of meiosis (GO:0045836) | 2.75672648 |
| 112 | cell proliferation involved in kidney development (GO:0072111) | 2.75081974 |
| 113 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.74950226 |
| 114 | axon ensheathment in central nervous system (GO:0032291) | 2.74611051 |
| 115 | central nervous system myelination (GO:0022010) | 2.74611051 |
| 116 | mesenchymal cell development (GO:0014031) | 2.74230002 |
| 117 | adult walking behavior (GO:0007628) | 2.74151317 |
| 118 | central nervous system neuron axonogenesis (GO:0021955) | 2.73829603 |
| 119 | smooth muscle cell differentiation (GO:0051145) | 2.72892569 |
| 120 | negative regulation of dendrite development (GO:2000171) | 2.71792580 |
| 121 | positive regulation of astrocyte differentiation (GO:0048711) | 2.71458239 |
| 122 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.70987727 |
| 123 | detection of light stimulus involved in visual perception (GO:0050908) | 2.70987727 |
| 124 | reflex (GO:0060004) | 2.70423577 |
| 125 | neuronal action potential propagation (GO:0019227) | 2.69023463 |
| 126 | retinoic acid metabolic process (GO:0042573) | 2.68789153 |
| 127 | mammary gland epithelial cell differentiation (GO:0060644) | 2.66043875 |
| 128 | regulation of pigment cell differentiation (GO:0050932) | 2.64785744 |
| 129 | mesenchymal cell proliferation (GO:0010463) | 2.64348732 |
| 130 | respiratory tube development (GO:0030323) | 2.63397326 |
| 131 | hair cell differentiation (GO:0035315) | 2.61808118 |
| 132 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.61546002 |
| 133 | regulation of water loss via skin (GO:0033561) | 2.61198859 |
| 134 | regulation of heart morphogenesis (GO:2000826) | 2.60570246 |
| 135 | synapse assembly (GO:0007416) | 2.60569426 |
| 136 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.59155656 |
| 137 | sympathetic nervous system development (GO:0048485) | 2.58703115 |
| 138 | proline transport (GO:0015824) | 2.57156770 |
| 139 | positive regulation of meiotic cell cycle (GO:0051446) | 2.56207250 |
| 140 | presynaptic membrane organization (GO:0097090) | 2.53697006 |
| 141 | cell differentiation involved in metanephros development (GO:0072202) | 2.52998856 |
| 142 | neuromuscular synaptic transmission (GO:0007274) | 2.52320764 |
| 143 | glutamate secretion (GO:0014047) | 2.52208117 |
| 144 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.52034386 |
| 145 | kidney morphogenesis (GO:0060993) | 2.51712653 |
| 146 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.51341858 |
| 147 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.51276862 |
| 148 | regulation of protein kinase C signaling (GO:0090036) | 2.50974028 |
| 149 | single strand break repair (GO:0000012) | 2.50730464 |
| 150 | exploration behavior (GO:0035640) | 2.50725178 |
| 151 | behavioral fear response (GO:0001662) | 2.50586080 |
| 152 | behavioral defense response (GO:0002209) | 2.50586080 |
| 153 | peristalsis (GO:0030432) | 2.50252552 |
| 154 | cranial nerve structural organization (GO:0021604) | 2.50066390 |
| 155 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.49784755 |
| 156 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.48695664 |
| 157 | mitochondrion transport along microtubule (GO:0047497) | 2.47734885 |
| 158 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.47734885 |
| 159 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.46890786 |
| 160 | membrane depolarization (GO:0051899) | 2.46866619 |
| 161 | positive regulation of chondrocyte differentiation (GO:0032332) | 2.46808826 |
| 162 | locomotory exploration behavior (GO:0035641) | 2.46625670 |
| 163 | startle response (GO:0001964) | 2.45928810 |
| 164 | dendrite morphogenesis (GO:0048813) | 2.45620230 |
| 165 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.45618764 |
| 166 | behavioral response to nicotine (GO:0035095) | 2.44515074 |
| 167 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.44479603 |
| 168 | mesenchymal cell differentiation (GO:0048762) | 2.44324017 |
| 169 | notochord development (GO:0030903) | 2.44303570 |
| 170 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.44290740 |
| 171 | pre-miRNA processing (GO:0031054) | 2.43987910 |
| 172 | regulation of transcription involved in cell fate commitment (GO:0060850) | 2.43069057 |
| 173 | regulation of postsynaptic membrane potential (GO:0060078) | 2.42557527 |
| 174 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.42459744 |
| 175 | DNA double-strand break processing (GO:0000729) | 2.41640189 |
| 176 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.40997535 |
| 177 | glycosphingolipid biosynthetic process (GO:0006688) | 2.40666891 |
| 178 | cochlea development (GO:0090102) | 2.40165096 |
| 179 | cranial nerve morphogenesis (GO:0021602) | 2.39300576 |
| 180 | regulation of respiratory system process (GO:0044065) | 2.39155987 |
| 181 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.37810558 |
| 182 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.37799727 |
| 183 | atrial cardiac muscle cell action potential (GO:0086014) | 2.37514777 |
| 184 | behavioral response to cocaine (GO:0048148) | 2.37170867 |
| 185 | auditory behavior (GO:0031223) | 2.36988242 |
| 186 | olfactory bulb development (GO:0021772) | 2.36693753 |
| 187 | * neurotransmitter secretion (GO:0007269) | 2.36442547 |
| 188 | adult behavior (GO:0030534) | 2.34625035 |
| 189 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.34311619 |
| 190 | synapse organization (GO:0050808) | 2.33007061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.88689370 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.41895762 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.99361137 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.91448049 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.88807653 |
| 6 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.78397798 |
| 7 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.74587377 |
| 8 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.73834834 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.59598747 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.55790445 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.54033026 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.53197240 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.53133716 |
| 14 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.47810075 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.46860123 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.42561243 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.37664490 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.37664490 |
| 19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.37075745 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.36430978 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.34586414 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34220164 |
| 23 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.33793320 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.24372538 |
| 25 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.15798153 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.14377491 |
| 27 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.08032269 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.05171944 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00523257 |
| 30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.00372915 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99701064 |
| 32 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.98083130 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.95437772 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.94760108 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.90230667 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.82714317 |
| 37 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82493712 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.81663247 |
| 39 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.80068019 |
| 40 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80068019 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78568300 |
| 42 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76761930 |
| 43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.73773110 |
| 44 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71727326 |
| 45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.70715034 |
| 46 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.68470786 |
| 47 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.67257558 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.64691641 |
| 49 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.63035412 |
| 50 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.63035412 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.62755136 |
| 52 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.62628864 |
| 53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.59859481 |
| 54 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.53377910 |
| 55 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.53333668 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.49371542 |
| 57 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.47682946 |
| 58 | TP53_16413492_ChIP-PET_HCT116_Human | 1.46772142 |
| 59 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.46471382 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41795145 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41744018 |
| 62 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.40551925 |
| 63 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39999932 |
| 64 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.38010664 |
| 65 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36544945 |
| 66 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.36497569 |
| 67 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.35704064 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34868591 |
| 69 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33019186 |
| 70 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.32418539 |
| 71 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32040545 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.31771118 |
| 73 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.31466061 |
| 74 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.31403974 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31162542 |
| 76 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.31119855 |
| 77 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30452297 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30204825 |
| 79 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.28993092 |
| 80 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27425006 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.27029327 |
| 82 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.25215440 |
| 83 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23824822 |
| 84 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.23366766 |
| 85 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22323379 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.22241119 |
| 87 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21659261 |
| 88 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20588160 |
| 89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20526617 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20212765 |
| 91 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20206724 |
| 92 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.19835326 |
| 93 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18588378 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18002439 |
| 95 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17974354 |
| 96 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17285974 |
| 97 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17220862 |
| 98 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16757174 |
| 99 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16581190 |
| 100 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.16220457 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13178533 |
| 102 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.12630196 |
| 103 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.12228027 |
| 104 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11364851 |
| 105 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.11209180 |
| 106 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10951082 |
| 107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10886780 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10886780 |
| 109 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10510859 |
| 110 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10189621 |
| 111 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09161321 |
| 112 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.08681684 |
| 113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08442846 |
| 114 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08019524 |
| 115 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07497077 |
| 116 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.07292795 |
| 117 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07262456 |
| 118 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.07178644 |
| 119 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.06540267 |
| 120 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06442507 |
| 121 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06082073 |
| 122 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05577498 |
| 123 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05313058 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04637231 |
| 125 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04273802 |
| 126 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.03987010 |
| 127 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.03260065 |
| 128 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.02953968 |
| 129 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02793207 |
| 130 | JUN_21703547_ChIP-Seq_K562_Human | 1.02746618 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02240700 |
| 132 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01984701 |
| 133 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01530535 |
| 134 | * AR_19668381_ChIP-Seq_PC3_Human | 1.01463690 |
| 135 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00777628 |
| 136 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.00697081 |
| 137 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00603742 |
| 138 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00603742 |
| 139 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00366397 |
| 140 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99724222 |
| 141 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.99036202 |
| 142 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99030364 |
| 143 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98799679 |
| 144 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98743172 |
| 145 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98697936 |
| 146 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97860478 |
| 147 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.97563636 |
| 148 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.96185187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 5.17450855 |
| 2 | MP0003136_yellow_coat_color | 5.12713367 |
| 3 | MP0009379_abnormal_foot_pigmentation | 4.08832914 |
| 4 | MP0005275_abnormal_skin_tensile | 3.96030263 |
| 5 | MP0000566_synostosis | 3.57009560 |
| 6 | MP0002736_abnormal_nociception_after | 3.06781625 |
| 7 | MP0004381_abnormal_hair_follicle | 2.95072811 |
| 8 | MP0002735_abnormal_chemical_nociception | 2.91217301 |
| 9 | MP0002249_abnormal_larynx_morphology | 2.67335826 |
| 10 | MP0002796_impaired_skin_barrier | 2.67235321 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.64985526 |
| 12 | MP0009046_muscle_twitch | 2.60299198 |
| 13 | MP0002098_abnormal_vibrissa_morphology | 2.58446726 |
| 14 | MP0001188_hyperpigmentation | 2.56923401 |
| 15 | MP0003890_abnormal_embryonic-extraembry | 2.55798119 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.55274637 |
| 17 | MP0003941_abnormal_skin_development | 2.54055293 |
| 18 | MP0000579_abnormal_nail_morphology | 2.50225851 |
| 19 | MP0002822_catalepsy | 2.45006848 |
| 20 | MP0005409_darkened_coat_color | 2.44458596 |
| 21 | MP0003724_increased_susceptibility_to | 2.32722398 |
| 22 | MP0006292_abnormal_olfactory_placode | 2.25937429 |
| 23 | MP0001529_abnormal_vocalization | 2.19546136 |
| 24 | MP0002272_abnormal_nervous_system | 2.17250641 |
| 25 | MP0008877_abnormal_DNA_methylation | 2.11643307 |
| 26 | MP0001984_abnormal_olfaction | 2.08226651 |
| 27 | MP0003880_abnormal_central_pattern | 2.06871023 |
| 28 | MP0002102_abnormal_ear_morphology | 2.03318734 |
| 29 | MP0000049_abnormal_middle_ear | 1.96119460 |
| 30 | MP0002064_seizures | 1.90323429 |
| 31 | MP0002009_preneoplasia | 1.89009978 |
| 32 | MP0000569_abnormal_digit_pigmentation | 1.82066183 |
| 33 | MP0002063_abnormal_learning/memory/cond | 1.81948331 |
| 34 | MP0010678_abnormal_skin_adnexa | 1.76244404 |
| 35 | MP0002938_white_spotting | 1.75355503 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.72766614 |
| 37 | MP0003828_pulmonary_edema | 1.71076694 |
| 38 | MP0001346_abnormal_lacrimal_gland | 1.70102498 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.69318860 |
| 40 | MP0009250_abnormal_appendicular_skeleto | 1.68982584 |
| 41 | MP0000762_abnormal_tongue_morphology | 1.67572946 |
| 42 | MP0003385_abnormal_body_wall | 1.65734050 |
| 43 | MP0001970_abnormal_pain_threshold | 1.65269301 |
| 44 | MP0002254_reproductive_system_inflammat | 1.64046739 |
| 45 | MP0002282_abnormal_trachea_morphology | 1.59101581 |
| 46 | MP0004133_heterotaxia | 1.55434769 |
| 47 | MP0002733_abnormal_thermal_nociception | 1.55176821 |
| 48 | MP0000955_abnormal_spinal_cord | 1.54556333 |
| 49 | MP0005386_behavior/neurological_phenoty | 1.51104130 |
| 50 | MP0004924_abnormal_behavior | 1.51104130 |
| 51 | MP0005171_absent_coat_pigmentation | 1.47568722 |
| 52 | MP0003646_muscle_fatigue | 1.44925530 |
| 53 | MP0002751_abnormal_autonomic_nervous | 1.43291950 |
| 54 | MP0003122_maternal_imprinting | 1.42541444 |
| 55 | MP0008057_abnormal_DNA_replication | 1.42201983 |
| 56 | MP0004272_abnormal_basement_membrane | 1.40069139 |
| 57 | MP0002184_abnormal_innervation | 1.38537652 |
| 58 | MP0005501_abnormal_skin_physiology | 1.38012391 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 1.37844452 |
| 60 | MP0001986_abnormal_taste_sensitivity | 1.36756891 |
| 61 | MP0001485_abnormal_pinna_reflex | 1.34895295 |
| 62 | MP0002177_abnormal_outer_ear | 1.33620771 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.33539684 |
| 64 | MP0003195_calcinosis | 1.32941351 |
| 65 | MP0004811_abnormal_neuron_physiology | 1.30946136 |
| 66 | MP0001968_abnormal_touch/_nociception | 1.30934197 |
| 67 | MP0004142_abnormal_muscle_tone | 1.29562705 |
| 68 | MP0003718_maternal_effect | 1.28845990 |
| 69 | MP0008872_abnormal_physiological_respon | 1.24412505 |
| 70 | MP0005623_abnormal_meninges_morphology | 1.23702187 |
| 71 | MP0003121_genomic_imprinting | 1.22423266 |
| 72 | * MP0002882_abnormal_neuron_morphology | 1.20355128 |
| 73 | MP0000428_abnormal_craniofacial_morphol | 1.19372965 |
| 74 | MP0003119_abnormal_digestive_system | 1.17155241 |
| 75 | MP0000377_abnormal_hair_follicle | 1.17114915 |
| 76 | MP0004742_abnormal_vestibular_system | 1.14075542 |
| 77 | MP0008058_abnormal_DNA_repair | 1.10856418 |
| 78 | MP0005646_abnormal_pituitary_gland | 1.10498562 |
| 79 | MP0005508_abnormal_skeleton_morphology | 1.09146553 |
| 80 | MP0001486_abnormal_startle_reflex | 1.09017900 |
| 81 | MP0002229_neurodegeneration | 1.08891771 |
| 82 | MP0002752_abnormal_somatic_nervous | 1.07612745 |
| 83 | MP0000778_abnormal_nervous_system | 1.07008327 |
| 84 | MP0000372_irregular_coat_pigmentation | 1.06417484 |
| 85 | MP0005248_abnormal_Harderian_gland | 1.06090104 |
| 86 | MP0003755_abnormal_palate_morphology | 1.05993834 |
| 87 | MP0003938_abnormal_ear_development | 1.05977097 |
| 88 | MP0000163_abnormal_cartilage_morphology | 1.04170866 |
| 89 | MP0005253_abnormal_eye_physiology | 1.04010478 |
| 90 | MP0001340_abnormal_eyelid_morphology | 1.02831677 |
| 91 | MP0002116_abnormal_craniofacial_bone | 1.02801762 |
| 92 | MP0009384_cardiac_valve_regurgitation | 1.01661804 |
| 93 | MP0004270_analgesia | 1.00156218 |
| 94 | MP0002066_abnormal_motor_capabilities/c | 0.99910869 |
| 95 | MP0010771_integument_phenotype | 0.99165333 |
| 96 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98527587 |
| 97 | MP0005595_abnormal_vascular_smooth | 0.97216402 |
| 98 | MP0002090_abnormal_vision | 0.96711499 |
| 99 | MP0003633_abnormal_nervous_system | 0.96586674 |
| 100 | MP0000383_abnormal_hair_follicle | 0.96511506 |
| 101 | MP0000026_abnormal_inner_ear | 0.95570693 |
| 102 | MP0002152_abnormal_brain_morphology | 0.95256768 |
| 103 | MP0001293_anophthalmia | 0.94267773 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.93567417 |
| 105 | MP0002233_abnormal_nose_morphology | 0.91870637 |
| 106 | * MP0003861_abnormal_nervous_system | 0.91776039 |
| 107 | MP0001958_emphysema | 0.89257633 |
| 108 | MP0002557_abnormal_social/conspecific_i | 0.88107656 |
| 109 | MP0000631_abnormal_neuroendocrine_gland | 0.87609167 |
| 110 | MP0001440_abnormal_grooming_behavior | 0.87181085 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.85305357 |
| 112 | MP0006138_congestive_heart_failure | 0.85261947 |
| 113 | MP0005394_taste/olfaction_phenotype | 0.84646244 |
| 114 | MP0005499_abnormal_olfactory_system | 0.84646244 |
| 115 | MP0009745_abnormal_behavioral_response | 0.84419219 |
| 116 | MP0003303_peritoneal_inflammation | 0.84140465 |
| 117 | MP0003937_abnormal_limbs/digits/tail_de | 0.83899160 |
| 118 | MP0005645_abnormal_hypothalamus_physiol | 0.83891372 |
| 119 | MP0002638_abnormal_pupillary_reflex | 0.82146747 |
| 120 | MP0003631_nervous_system_phenotype | 0.81267911 |
| 121 | MP0003698_abnormal_male_reproductive | 0.80675207 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.79421687 |
| 123 | MP0004885_abnormal_endolymph | 0.79158347 |
| 124 | MP0005174_abnormal_tail_pigmentation | 0.79145078 |
| 125 | MP0002933_joint_inflammation | 0.78863408 |
| 126 | MP0005367_renal/urinary_system_phenotyp | 0.78125183 |
| 127 | MP0000516_abnormal_urinary_system | 0.78125183 |
| 128 | MP0001216_abnormal_epidermal_layer | 0.77891450 |
| 129 | MP0006072_abnormal_retinal_apoptosis | 0.77832425 |
| 130 | * MP0003635_abnormal_synaptic_transmissio | 0.77644913 |
| 131 | MP0000647_abnormal_sebaceous_gland | 0.75997227 |
| 132 | MP0002060_abnormal_skin_morphology | 0.75609094 |
| 133 | MP0010030_abnormal_orbit_morphology | 0.75111056 |
| 134 | MP0005195_abnormal_posterior_eye | 0.74874199 |
| 135 | MP0001919_abnormal_reproductive_system | 0.74646353 |
| 136 | MP0008569_lethality_at_weaning | 0.73778418 |
| 137 | MP0000465_gastrointestinal_hemorrhage | 0.72414922 |
| 138 | MP0002133_abnormal_respiratory_system | 0.71751655 |
| 139 | MP0005388_respiratory_system_phenotype | 0.71751655 |
| 140 | MP0003566_abnormal_cell_adhesion | 0.71505879 |
| 141 | MP0001324_abnormal_eye_pigmentation | 0.71234665 |
| 142 | MP0002653_abnormal_ependyma_morphology | 0.69643122 |
| 143 | MP0005165_increased_susceptibility_to | 0.69207578 |
| 144 | MP0002160_abnormal_reproductive_system | 0.69015219 |
| 145 | MP0002069_abnormal_eating/drinking_beha | 0.68980812 |
| 146 | MP0000432_abnormal_head_morphology | 0.68380341 |
| 147 | MP0005197_abnormal_uvea_morphology | 0.68311630 |
| 148 | MP0004147_increased_porphyrin_level | 0.66352616 |
| 149 | MP0005390_skeleton_phenotype | 0.66195979 |
| 150 | MP0002067_abnormal_sensory_capabilities | 0.64876116 |
| 151 | MP0003942_abnormal_urinary_system | 0.64839363 |
| 152 | MP0001177_atelectasis | 0.63285074 |
| 153 | MP0004859_abnormal_synaptic_plasticity | 0.62673921 |
| 154 | MP0002572_abnormal_emotion/affect_behav | 0.62567607 |
| 155 | MP0002111_abnormal_tail_morphology | 0.62318810 |
| 156 | MP0004085_abnormal_heartbeat | 0.62120280 |
| 157 | MP0001963_abnormal_hearing_physiology | 0.61644292 |
| 158 | MP0001905_abnormal_dopamine_level | 0.60237395 |
| 159 | MP0000613_abnormal_salivary_gland | 0.59896273 |
| 160 | MP0002109_abnormal_limb_morphology | 0.59429560 |
| 161 | MP0001502_abnormal_circadian_rhythm | 0.59275746 |
| 162 | MP0008789_abnormal_olfactory_epithelium | 0.58758824 |
| 163 | MP0003137_abnormal_impulse_conducting | 0.58741623 |
| 164 | MP0003787_abnormal_imprinting | 0.58537816 |
| 165 | MP0002115_abnormal_skeleton_extremities | 0.57039670 |
| 166 | MP0003935_abnormal_craniofacial_develop | 0.57005585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of secondary sexual hair (HP:0009888) | 6.23700270 |
| 2 | Abnormality of the axillary hair (HP:0100134) | 6.23700270 |
| 3 | Increased IgE level (HP:0003212) | 6.10079489 |
| 4 | Humeroradial synostosis (HP:0003041) | 5.75714931 |
| 5 | Synostosis involving the elbow (HP:0003938) | 5.75714931 |
| 6 | Abnormal sex determination (HP:0012244) | 5.13581962 |
| 7 | Sex reversal (HP:0012245) | 5.13581962 |
| 8 | Onycholysis (HP:0001806) | 4.90183018 |
| 9 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.44342788 |
| 10 | Focal seizures (HP:0007359) | 4.06559269 |
| 11 | Hyperventilation (HP:0002883) | 3.71427828 |
| 12 | Neonatal short-limb short stature (HP:0008921) | 3.70850451 |
| 13 | True hermaphroditism (HP:0010459) | 3.49809778 |
| 14 | Abnormality of the labia minora (HP:0012880) | 3.42996640 |
| 15 | Concave nail (HP:0001598) | 3.34827094 |
| 16 | Sparse scalp hair (HP:0002209) | 3.27747118 |
| 17 | Oligodactyly (HP:0012165) | 3.23444012 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.21965905 |
| 19 | Atonic seizures (HP:0010819) | 3.13583936 |
| 20 | Occipital encephalocele (HP:0002085) | 3.11395483 |
| 21 | Hypoplasia of the iris (HP:0007676) | 3.09136457 |
| 22 | Myokymia (HP:0002411) | 3.06693844 |
| 23 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.06302449 |
| 24 | Aplasia of the phalanges of the hand (HP:0009802) | 3.06302449 |
| 25 | Aplasia involving bones of the extremities (HP:0009825) | 3.06302449 |
| 26 | Broad-based gait (HP:0002136) | 3.05414677 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 3.05321522 |
| 28 | Bronchomalacia (HP:0002780) | 2.96398041 |
| 29 | Dialeptic seizures (HP:0011146) | 2.87962006 |
| 30 | Epileptic encephalopathy (HP:0200134) | 2.84073201 |
| 31 | Dry hair (HP:0011359) | 2.78326728 |
| 32 | Drooling (HP:0002307) | 2.76194246 |
| 33 | Popliteal pterygium (HP:0009756) | 2.71985366 |
| 34 | Hypotrichosis (HP:0001006) | 2.68655603 |
| 35 | Tracheomalacia (HP:0002779) | 2.67380083 |
| 36 | Inability to walk (HP:0002540) | 2.67177712 |
| 37 | Absent speech (HP:0001344) | 2.67003654 |
| 38 | Obstructive sleep apnea (HP:0002870) | 2.66778862 |
| 39 | Congenital sensorineural hearing impairment (HP:0008527) | 2.62356733 |
| 40 | Septo-optic dysplasia (HP:0100842) | 2.62136067 |
| 41 | Protruding tongue (HP:0010808) | 2.61535055 |
| 42 | Erythroderma (HP:0001019) | 2.60846863 |
| 43 | Hepatoblastoma (HP:0002884) | 2.53913051 |
| 44 | 11 pairs of ribs (HP:0000878) | 2.52078378 |
| 45 | Intestinal atresia (HP:0011100) | 2.50803181 |
| 46 | Optic nerve hypoplasia (HP:0000609) | 2.48736547 |
| 47 | Hypophosphatemic rickets (HP:0004912) | 2.47180797 |
| 48 | Acanthosis nigricans (HP:0000956) | 2.45983959 |
| 49 | Excessive salivation (HP:0003781) | 2.45269859 |
| 50 | Pancreatic cysts (HP:0001737) | 2.44891295 |
| 51 | Retinal dysplasia (HP:0007973) | 2.43930218 |
| 52 | Generalized tonic-clonic seizures (HP:0002069) | 2.43066807 |
| 53 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.42769206 |
| 54 | Hypothermia (HP:0002045) | 2.42223633 |
| 55 | Renal tubular acidosis (HP:0001947) | 2.40622729 |
| 56 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.36990972 |
| 57 | Amyotrophic lateral sclerosis (HP:0007354) | 2.36210589 |
| 58 | Absent hair (HP:0002298) | 2.34759758 |
| 59 | Limb dystonia (HP:0002451) | 2.32936566 |
| 60 | Follicular hyperkeratosis (HP:0007502) | 2.30749414 |
| 61 | Vaginal atresia (HP:0000148) | 2.28188209 |
| 62 | Genital tract atresia (HP:0001827) | 2.28153919 |
| 63 | Anophthalmia (HP:0000528) | 2.27904814 |
| 64 | Natal tooth (HP:0000695) | 2.25226716 |
| 65 | Fibular hypoplasia (HP:0003038) | 2.23050597 |
| 66 | Gait imbalance (HP:0002141) | 2.21791736 |
| 67 | Colon cancer (HP:0003003) | 2.21483080 |
| 68 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.20340447 |
| 69 | Bifid scrotum (HP:0000048) | 2.19591162 |
| 70 | Abnormality of macular pigmentation (HP:0008002) | 2.18399966 |
| 71 | Polyphagia (HP:0002591) | 2.18035462 |
| 72 | Congenital stationary night blindness (HP:0007642) | 2.17882818 |
| 73 | Soft skin (HP:0000977) | 2.17641599 |
| 74 | Bifid tongue (HP:0010297) | 2.16109560 |
| 75 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.15820590 |
| 76 | Woolly hair (HP:0002224) | 2.15149691 |
| 77 | Brittle hair (HP:0002299) | 2.15075378 |
| 78 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.14176310 |
| 79 | Nephronophthisis (HP:0000090) | 2.13291135 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.13274200 |
| 81 | Action tremor (HP:0002345) | 2.12724255 |
| 82 | Progressive inability to walk (HP:0002505) | 2.11533055 |
| 83 | Abnormality of the astrocytes (HP:0100707) | 2.11397881 |
| 84 | Astrocytoma (HP:0009592) | 2.11397881 |
| 85 | Median cleft lip (HP:0000161) | 2.11273456 |
| 86 | Pancreatic fibrosis (HP:0100732) | 2.10314775 |
| 87 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.10287626 |
| 88 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.08665048 |
| 89 | Corneal dystrophy (HP:0001131) | 2.08412350 |
| 90 | Abnormality of midbrain morphology (HP:0002418) | 2.07941994 |
| 91 | Molar tooth sign on MRI (HP:0002419) | 2.07941994 |
| 92 | Lissencephaly (HP:0001339) | 2.07615064 |
| 93 | Knee flexion contracture (HP:0006380) | 2.07034709 |
| 94 | Myelomeningocele (HP:0002475) | 2.06740240 |
| 95 | Focal motor seizures (HP:0011153) | 2.06319546 |
| 96 | Ependymoma (HP:0002888) | 2.05951708 |
| 97 | Renal hypoplasia (HP:0000089) | 2.05776798 |
| 98 | Genetic anticipation (HP:0003743) | 2.05183679 |
| 99 | Anhidrosis (HP:0000970) | 2.03598684 |
| 100 | Midline defect of the nose (HP:0004122) | 2.02727796 |
| 101 | Hemiparesis (HP:0001269) | 2.02084559 |
| 102 | Abolished electroretinogram (ERG) (HP:0000550) | 2.01957641 |
| 103 | Hypoplastic left heart (HP:0004383) | 2.01938918 |
| 104 | Nonprogressive disorder (HP:0003680) | 2.01831144 |
| 105 | Aqueductal stenosis (HP:0002410) | 2.01273626 |
| 106 | Chronic hepatic failure (HP:0100626) | 2.00326627 |
| 107 | Hypoplastic heart (HP:0001961) | 2.00308391 |
| 108 | Corneal erosion (HP:0200020) | 2.00185623 |
| 109 | Epileptiform EEG discharges (HP:0011182) | 1.99993149 |
| 110 | Small hand (HP:0200055) | 1.99612275 |
| 111 | Attenuation of retinal blood vessels (HP:0007843) | 1.97982407 |
| 112 | Abnormal pupillary function (HP:0007686) | 1.97066618 |
| 113 | Hyperglycinemia (HP:0002154) | 1.96705527 |
| 114 | Thyroid-stimulating hormone excess (HP:0002925) | 1.96677679 |
| 115 | Cutaneous finger syndactyly (HP:0010554) | 1.96217987 |
| 116 | Absence seizures (HP:0002121) | 1.94460356 |
| 117 | Bilateral microphthalmos (HP:0007633) | 1.94311367 |
| 118 | Stomach cancer (HP:0012126) | 1.94071989 |
| 119 | Hemiplegia (HP:0002301) | 1.93624857 |
| 120 | Overgrowth (HP:0001548) | 1.92910664 |
| 121 | Thickened helices (HP:0000391) | 1.92602022 |
| 122 | Amblyopia (HP:0000646) | 1.92578210 |
| 123 | Cupped ear (HP:0000378) | 1.92240537 |
| 124 | Hypsarrhythmia (HP:0002521) | 1.90033317 |
| 125 | Abnormality of dental color (HP:0011073) | 1.89685029 |
| 126 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.89642208 |
| 127 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.89397840 |
| 128 | Abnormality of the humeroradial joint (HP:0100744) | 1.89251119 |
| 129 | Microglossia (HP:0000171) | 1.89176605 |
| 130 | EEG with generalized epileptiform discharges (HP:0011198) | 1.89102033 |
| 131 | Cutaneous syndactyly (HP:0012725) | 1.88023637 |
| 132 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.87746086 |
| 133 | Fragile nails (HP:0001808) | 1.86911514 |
| 134 | Pendular nystagmus (HP:0012043) | 1.86487854 |
| 135 | Labial hypoplasia (HP:0000066) | 1.86291251 |
| 136 | Oligodactyly (hands) (HP:0001180) | 1.86188457 |
| 137 | Glioma (HP:0009733) | 1.85907531 |
| 138 | Medial flaring of the eyebrow (HP:0010747) | 1.85858600 |
| 139 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.85508572 |
| 140 | Impaired social interactions (HP:0000735) | 1.84210652 |
| 141 | Abnormal social behavior (HP:0012433) | 1.84210652 |
| 142 | Conical tooth (HP:0000698) | 1.84023407 |
| 143 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.83297504 |
| 144 | Advanced eruption of teeth (HP:0006288) | 1.82942500 |
| 145 | Renal tubular dysfunction (HP:0000124) | 1.81501752 |
| 146 | Supernumerary spleens (HP:0009799) | 1.80145447 |
| 147 | Abnormality of the renal medulla (HP:0100957) | 1.79124965 |
| 148 | Submucous cleft hard palate (HP:0000176) | 1.78927828 |
| 149 | Spastic gait (HP:0002064) | 1.78438068 |
| 150 | Scrotal hypoplasia (HP:0000046) | 1.78182643 |
| 151 | Birth length less than 3rd percentile (HP:0003561) | 1.78153478 |
| 152 | Abnormality of the nasolacrimal system (HP:0000614) | 1.78146864 |
| 153 | Urinary urgency (HP:0000012) | 1.78100013 |
| 154 | Febrile seizures (HP:0002373) | 1.77853541 |
| 155 | Atelectasis (HP:0100750) | 1.77836988 |
| 156 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.76939330 |
| 157 | Curly hair (HP:0002212) | 1.75780575 |
| 158 | Hyperglycinuria (HP:0003108) | 1.75699027 |
| 159 | Spastic tetraplegia (HP:0002510) | 1.74331618 |
| 160 | Absent eyebrow (HP:0002223) | 1.73717087 |
| 161 | Congenital primary aphakia (HP:0007707) | 1.73418290 |
| 162 | Reduced antithrombin III activity (HP:0001976) | 1.73269114 |
| 163 | Narrow forehead (HP:0000341) | 1.72678145 |
| 164 | Sleep apnea (HP:0010535) | 1.72653802 |
| 165 | Male pseudohermaphroditism (HP:0000037) | 1.72310684 |
| 166 | Type II lissencephaly (HP:0007260) | 1.71350915 |
| 167 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.70353220 |
| 168 | Short tibia (HP:0005736) | 1.70257678 |
| 169 | Volvulus (HP:0002580) | 1.69342696 |
| 170 | Palpebral edema (HP:0100540) | 1.69206257 |
| 171 | Recurrent corneal erosions (HP:0000495) | 1.69025086 |
| 172 | Coronal craniosynostosis (HP:0004440) | 1.68869678 |
| 173 | Hypoplastic female external genitalia (HP:0012815) | 1.68809237 |
| 174 | Dysdiadochokinesis (HP:0002075) | 1.68720960 |
| 175 | Sclerocornea (HP:0000647) | 1.68468341 |
| 176 | Abnormality of the pubic bones (HP:0003172) | 1.68248378 |
| 177 | Hypoparathyroidism (HP:0000829) | 1.67884249 |
| 178 | Anencephaly (HP:0002323) | 1.67623295 |
| 179 | Aplasia cutis congenita (HP:0001057) | 1.67565144 |
| 180 | Abnormality of the right ventricle (HP:0001707) | 1.67363624 |
| 181 | Long nose (HP:0003189) | 1.67341679 |
| 182 | Morphological abnormality of the middle ear (HP:0008609) | 1.67335601 |
| 183 | Abnormality of the lacrimal duct (HP:0011481) | 1.67229046 |
| 184 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.67052334 |
| 185 | Abnormality of the corticospinal tract (HP:0002492) | 1.66553752 |
| 186 | Absent septum pellucidum (HP:0001331) | 1.65890019 |
| 187 | Specific learning disability (HP:0001328) | 1.65387356 |
| 188 | Laryngomalacia (HP:0001601) | 1.65307853 |
| 189 | Metabolic alkalosis (HP:0200114) | 1.65230022 |
| 190 | Premature rupture of membranes (HP:0001788) | 1.65181902 |
| 191 | Dandy-Walker malformation (HP:0001305) | 1.64903962 |
| 192 | Absent hand (HP:0004050) | 1.64775134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.74541614 |
| 2 | IRAK3 | 3.63409721 |
| 3 | FRK | 3.48388603 |
| 4 | TNIK | 3.39739483 |
| 5 | FER | 3.17759410 |
| 6 | MKNK2 | 3.08441937 |
| 7 | FES | 2.65342129 |
| 8 | WNK3 | 2.64652147 |
| 9 | MUSK | 2.55747269 |
| 10 | TRIM28 | 2.35424160 |
| 11 | MAP3K4 | 2.32277518 |
| 12 | NUAK1 | 2.29236932 |
| 13 | EPHA4 | 2.24555761 |
| 14 | NLK | 2.19015013 |
| 15 | PNCK | 2.02400494 |
| 16 | BCR | 2.02018116 |
| 17 | MAP4K2 | 1.98715450 |
| 18 | PBK | 1.95760359 |
| 19 | BMPR1B | 1.95524457 |
| 20 | HIPK2 | 1.90192648 |
| 21 | CAMK1G | 1.76511615 |
| 22 | PINK1 | 1.75262705 |
| 23 | YES1 | 1.68231573 |
| 24 | PIM2 | 1.65561203 |
| 25 | CSNK1G2 | 1.64268680 |
| 26 | PKN1 | 1.64135735 |
| 27 | TLK1 | 1.55938593 |
| 28 | MKNK1 | 1.55104760 |
| 29 | LATS1 | 1.51638769 |
| 30 | MAPK13 | 1.50987938 |
| 31 | EPHA3 | 1.46569273 |
| 32 | STK16 | 1.44054153 |
| 33 | MAP2K7 | 1.43467904 |
| 34 | CSNK1G3 | 1.37969576 |
| 35 | STK24 | 1.37567084 |
| 36 | PRKCG | 1.37082742 |
| 37 | MAPK15 | 1.35628518 |
| 38 | GRK1 | 1.33535806 |
| 39 | NME1 | 1.30556663 |
| 40 | CLK1 | 1.29402003 |
| 41 | CAMK1 | 1.28957488 |
| 42 | PLK2 | 1.28863982 |
| 43 | DMPK | 1.28752952 |
| 44 | ACVR1B | 1.22921407 |
| 45 | TIE1 | 1.18375998 |
| 46 | IRAK1 | 1.17182349 |
| 47 | MAP3K12 | 1.05341296 |
| 48 | DAPK2 | 1.02943093 |
| 49 | ROCK1 | 1.01683743 |
| 50 | PLK3 | 1.00087528 |
| 51 | RPS6KL1 | 0.97294808 |
| 52 | RPS6KC1 | 0.97294808 |
| 53 | PRPF4B | 0.96186511 |
| 54 | RPS6KA2 | 0.95836035 |
| 55 | DYRK3 | 0.95362595 |
| 56 | EPHB2 | 0.95270967 |
| 57 | ADRBK2 | 0.89426954 |
| 58 | PRKCE | 0.89168911 |
| 59 | OXSR1 | 0.88196648 |
| 60 | BLK | 0.86702389 |
| 61 | PLK4 | 0.85333805 |
| 62 | UHMK1 | 0.85080963 |
| 63 | PRKD3 | 0.85012212 |
| 64 | IRAK4 | 0.83659796 |
| 65 | TEC | 0.83368449 |
| 66 | CDK5 | 0.83205349 |
| 67 | NTRK3 | 0.80917251 |
| 68 | FGFR2 | 0.80813255 |
| 69 | CAMKK2 | 0.80503892 |
| 70 | DAPK1 | 0.79736065 |
| 71 | ERBB3 | 0.79488316 |
| 72 | PHKG1 | 0.79438657 |
| 73 | PHKG2 | 0.79438657 |
| 74 | SIK2 | 0.78508528 |
| 75 | RPS6KA6 | 0.77472525 |
| 76 | CAMK2B | 0.77454990 |
| 77 | ADRBK1 | 0.77270560 |
| 78 | CAMK1D | 0.75237017 |
| 79 | BMPR2 | 0.75155757 |
| 80 | STK38L | 0.74628163 |
| 81 | EIF2AK2 | 0.73880185 |
| 82 | MARK1 | 0.73412431 |
| 83 | EPHB1 | 0.73230500 |
| 84 | CDK19 | 0.72944966 |
| 85 | TAF1 | 0.72476147 |
| 86 | PRKAA2 | 0.69435564 |
| 87 | DYRK1A | 0.68719623 |
| 88 | VRK1 | 0.68631739 |
| 89 | CSNK1D | 0.67417164 |
| 90 | NEK6 | 0.66657418 |
| 91 | MARK2 | 0.64795787 |
| 92 | CSNK1G1 | 0.63175244 |
| 93 | MAP2K4 | 0.62094113 |
| 94 | CSK | 0.61835444 |
| 95 | CSNK1A1L | 0.61679714 |
| 96 | MST4 | 0.60103951 |
| 97 | CAMK2D | 0.59422109 |
| 98 | MAPK4 | 0.59024291 |
| 99 | SGK223 | 0.58908396 |
| 100 | SGK494 | 0.58908396 |
| 101 | MAP2K2 | 0.57020331 |
| 102 | PRKCZ | 0.56869547 |
| 103 | INSRR | 0.56558244 |
| 104 | GRK5 | 0.56306564 |
| 105 | SIK3 | 0.55038543 |
| 106 | CSNK1E | 0.54878118 |
| 107 | NTRK2 | 0.54809783 |
| 108 | ZAK | 0.54672617 |
| 109 | TXK | 0.54249283 |
| 110 | CSNK1A1 | 0.53288712 |
| 111 | CAMK2A | 0.52800083 |
| 112 | IKBKB | 0.51515870 |
| 113 | STK3 | 0.50257953 |
| 114 | KSR1 | 0.48500339 |
| 115 | NME2 | 0.47797931 |
| 116 | ATM | 0.47525409 |
| 117 | AKT3 | 0.46915772 |
| 118 | PRKG1 | 0.46873152 |
| 119 | MAPK12 | 0.46249979 |
| 120 | BRSK2 | 0.46114791 |
| 121 | STK11 | 0.45555889 |
| 122 | DYRK2 | 0.44918007 |
| 123 | CDK3 | 0.44806159 |
| 124 | TYRO3 | 0.44741204 |
| 125 | TSSK6 | 0.44635409 |
| 126 | PLK1 | 0.44156068 |
| 127 | MAP3K14 | 0.43741856 |
| 128 | CDC7 | 0.43442406 |
| 129 | CDK18 | 0.42784679 |
| 130 | CAMK4 | 0.41767611 |
| 131 | BRD4 | 0.40948287 |
| 132 | CAMK2G | 0.40396981 |
| 133 | SGK2 | 0.40154181 |
| 134 | ATR | 0.40118932 |
| 135 | SRPK1 | 0.39426220 |
| 136 | MAPK7 | 0.39230404 |
| 137 | PAK3 | 0.38703446 |
| 138 | PRKACB | 0.38457349 |
| 139 | PAK6 | 0.38306635 |
| 140 | WEE1 | 0.37364097 |
| 141 | PRKACA | 0.37197003 |
| 142 | GRK7 | 0.37034221 |
| 143 | PRKD2 | 0.36912830 |
| 144 | PRKDC | 0.36831104 |
| 145 | PRKAA1 | 0.36830623 |
| 146 | MAPK10 | 0.35577255 |
| 147 | MINK1 | 0.35398292 |
| 148 | * GSK3B | 0.34888230 |
| 149 | HCK | 0.33985694 |
| 150 | LCK | 0.33819805 |
| 151 | IRAK2 | 0.32668825 |
| 152 | PRKG2 | 0.31284432 |
| 153 | RPS6KA5 | 0.30094365 |
| 154 | ABL1 | 0.28955216 |
| 155 | MAPK11 | 0.28765087 |
| 156 | DYRK1B | 0.28498691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retinol metabolism_Homo sapiens_hsa00830 | 2.43947596 |
| 2 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.23686366 |
| 3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.22124735 |
| 4 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.99803853 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 1.91679962 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.88463094 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83677867 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.81207906 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.73847565 |
| 10 | Melanogenesis_Homo sapiens_hsa04916 | 1.72380712 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.71822718 |
| 12 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.71585361 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.70108815 |
| 14 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68935591 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.68356515 |
| 16 | Axon guidance_Homo sapiens_hsa04360 | 1.68006947 |
| 17 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.59323395 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.59002638 |
| 19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.55860894 |
| 20 | Melanoma_Homo sapiens_hsa05218 | 1.53180385 |
| 21 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.52085909 |
| 22 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.48549033 |
| 23 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.47740516 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.46394178 |
| 25 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.45176129 |
| 26 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.41478415 |
| 27 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.39896867 |
| 28 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.34739351 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30310802 |
| 30 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.28598596 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.27251625 |
| 32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.25907889 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.25278489 |
| 34 | Morphine addiction_Homo sapiens_hsa05032 | 1.24227221 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.23593234 |
| 36 | Protein export_Homo sapiens_hsa03060 | 1.20052408 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19310597 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.17729488 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17650989 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.15985506 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15436747 |
| 42 | Salivary secretion_Homo sapiens_hsa04970 | 1.13452869 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.13243298 |
| 44 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.10695203 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.07934680 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06829540 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06336068 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.06083120 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05524715 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.05067654 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04307218 |
| 52 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.03365312 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99581316 |
| 54 | RNA polymerase_Homo sapiens_hsa03020 | 0.99450614 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.97505644 |
| 56 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96506210 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95824787 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94160261 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94004249 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.93170258 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92876325 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.90869529 |
| 63 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.90386878 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.90054829 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89213642 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88639194 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.88205290 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88029711 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87449446 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85902960 |
| 71 | Long-term depression_Homo sapiens_hsa04730 | 0.85697467 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85576714 |
| 73 | Tight junction_Homo sapiens_hsa04530 | 0.83913071 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.83846450 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.83619021 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.83323366 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83016717 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82953898 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82607337 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.81904531 |
| 81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81667435 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81221449 |
| 83 | Pathways in cancer_Homo sapiens_hsa05200 | 0.81200767 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80767738 |
| 85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.79320501 |
| 86 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78862934 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.78627536 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.76375122 |
| 89 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.75950979 |
| 90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75181223 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74653727 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.73906726 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73726389 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.73505332 |
| 95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72617072 |
| 96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69645398 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68410868 |
| 98 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.68011729 |
| 99 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67625539 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67509284 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66462244 |
| 102 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.64821716 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64666885 |
| 104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64251931 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63941895 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.63870763 |
| 107 | Homologous recombination_Homo sapiens_hsa03440 | 0.63469564 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63195920 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61264336 |
| 110 | RNA transport_Homo sapiens_hsa03013 | 0.60163033 |
| 111 | RNA degradation_Homo sapiens_hsa03018 | 0.59979519 |
| 112 | Allograft rejection_Homo sapiens_hsa05330 | 0.59870612 |
| 113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59419852 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.59063195 |
| 115 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58785111 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57323160 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.57063733 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56510582 |
| 119 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56290240 |
| 120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56145599 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55884170 |
| 122 | Ribosome_Homo sapiens_hsa03010 | 0.55327679 |
| 123 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54524223 |
| 124 | Olfactory transduction_Homo sapiens_hsa04740 | 0.54263979 |
| 125 | Asthma_Homo sapiens_hsa05310 | 0.54175240 |
| 126 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53654628 |
| 127 | Gap junction_Homo sapiens_hsa04540 | 0.52475868 |
| 128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51200882 |
| 129 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50780370 |
| 130 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50682824 |
| 131 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.50658579 |
| 132 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49726008 |
| 133 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.49457960 |
| 134 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49010206 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48791486 |
| 136 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48525798 |
| 137 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47991190 |
| 138 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47285856 |
| 139 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47141576 |
| 140 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47057085 |
| 141 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45810894 |
| 142 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.45733441 |
| 143 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45574920 |
| 144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45490626 |
| 145 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44758809 |
| 146 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44621929 |
| 147 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.44293607 |
| 148 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.44181533 |
| 149 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43486563 |
| 150 | Purine metabolism_Homo sapiens_hsa00230 | 0.43450326 |
| 151 | Alcoholism_Homo sapiens_hsa05034 | 0.43331699 |
| 152 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42781333 |
| 153 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40139209 |
| 154 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40053573 |
| 155 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37955709 |

